Intuitive Surgical(ISRG)
$407.24-13.71 (-3.26%)
ISRG
Intuitive Surgical stock drug pipeline
$407.24
At close:-13.71 (-3.26%)
Want to see ISRG full AI Analyst Report?
Intuitive Surgical (ISRG) Drug Pipeline
9,892 Followers
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Intuitive Surgical (ISRG) have in its pipeline
Intuitive Surgical ISRG is currently developing the following drugs: Shape-Sensing Robotic-Assisted Bronchoscopy With Cone-Beam Ct, Ct-Guided Percutaneous Lung Nodule Biopsy, Ion Endoluminal System, Filricianine, Administration Of Is-002, Firefly Fluorescent Imaging, Robotic-Assisted Laparoscopic Prostatectomy With Pelvic Lymph Node Dissection, Is-001, Is-002, No Treatment, Is-001, Is-001, Da Vinci Si/Xi Surgical System. These drug candidates are in various stages of clinical development as the company works toward FDA approval.

